Britannia Pharmaceuticals simplifies apomorphine delivery with new Pre-Filled Syringe

Main Category: Parkinson's Disease
Article Date: 11 Jan 2005 - 12:00 PDT

Current ratings for:
'Britannia Pharmaceuticals simplifies apomorphine delivery with new Pre-Filled Syringe'

Patient / Public:2 stars

2 (1 votes)

Healthcare Prof:not yet rated


Britannia Pharmaceuticals announces today the availability of the APO-go Pre-Filled Syringe (PFS), an easier to use presentation for Parkinson's disease patients using apomorphine by continuous infusion with an APO-go pump.

Patients requiring a continuous subcutaneous infusion of apomorphine use an APO-go pump to administer their drug. The new APO-go PFS contains a 5mg/ml concentration of apomorphine hydrochloride which is ready for transfer to a plastic syringe specifically designed for use with an APO-go pump. There is no longer a need to break ampoules thereby reducing the time of the preparation procedure.

The advantages to the new APO-go PFS include:

-- Quick and simple
-- Pre-dilution ensures accurate dosage
-- Reduced likelihood of spillage or contamination
-- No need to break ampoules thereby eliminating associated risks
-- Lower cost to NHS compared with separate APO-go and saline ampoules

James Carter, Marketing Manager for Britannia Pharmaceuticals commented, "The APO-go pump has been a major benefit to patients who require apomorphine infusions, being small, discreet and relatively easy to use. With our new APO-go PFS the time to prepare an infusion has been further reduced and its use eliminates the risk of injury that was possible when using glass ampoules and needles. Finally, being pre-diluted and ready for a quick and simple transfer, APO-go PFS represents good pharmaceutical practice."

An image to accompany this release is available for download if you CLICK HERE

-ends-

About Britannia Pharmaceuticals

Founded in 1981, Britannia Pharmaceuticals Limited is a United Kingdom-based pharmaceutical firm whose mission is to become a leading supplier of innovative products for niche medical conditions. The company has pioneered new treatments for some of the world's most debilitating conditions including asthma, Parkinson's disease, drug addiction, and migraine. In addition to these treatments, Britannia has also developed nasal and respiratory drug delivery technologies that are applicable to a range of treatments. Britannia is a Forum Bioscience company. Visit Britannia's website at http://www.britannia-pharm.co.uk.

Contacts:
James Carter
James.carter@forumgroup.co.uk
+44 (0) 1737 857759

Sue Glanville
sglanville@europrgroup.com
+44 (0) 20 8917 4923

Article adapted by Medical News Today from original press release.
Visit our parkinson's disease section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
James Carter. "Britannia Pharmaceuticals simplifies apomorphine delivery with new Pre-Filled Syringe." Medical News Today. MediLexicon, Intl., 11 Jan. 2005. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/18781.php>

APA
James Carter. (2005, January 11). "Britannia Pharmaceuticals simplifies apomorphine delivery with new Pre-Filled Syringe." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/18781.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Britannia Pharmaceuticals simplifies apomorphine delivery with new Pre-Filled Syringe'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Parkinson's Disease

What is Parkinson's Disease?

Parkinson's disease is a gradually progressive, degenerative neurologic disorder which typically impairs the patient's motor skills, speech, writing, as well as some other functions. Read more...

Most Popular Articles



Follow Our Parkinson's Disease News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Parkinson's Disease Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »